The FirstTake Podcast – Use of J&J’s COVID-19 vaccine paused in US amid safety concerns

FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss fallout from the decision by US authorities to pause roll out of Johnson & Johnson’s COVID-19 vaccine; take a look at new data for an investigational treatment being developed for essential tremor by Biogen and Sage Therapeutics; shed light on results from a physician survey suggesting safety concerns could dent confidence in JAK inhibitors for the treatment of atopic dermatitis; and ask whether GlaxoSmithKline can afford any further R&D slip-ups.

Listen here

Tags

Pharma

Biotech

COVID-19

Vaccines

Oncology

To read more ViewPoints articles, click here.